Literature DB >> 23099415

Circadian and sleep disorder in Huntington's disease.

A Jennifer Morton1.   

Abstract

Huntington's disease is a progressive neurological disorder that starts insidiously with motor, cognitive or psychiatric disturbance, and progresses through a distressing range of symptoms to end with a devastating loss of function, both motor and executive. There is a growing awareness that, in addition to cognitive and psychiatric symptoms, there are other important non-motor symptoms in HD, including sleep and circadian abnormalities. It is not clear if sleep-wake changes are caused directly by HD gene-related pathology, or if they are simply a consequence of having a neurodegenerative disease. From a patient point of view, the answer is irrelevant, since sleep and circadian disturbances are deleterious to good daily living, even in neurologically normal people. The assumption should be that, at the very least, sleep and/or circadian disturbance in HD patients will contribute to their symptoms. At worst, they may contribute to the progressive decline in HD. Here I review the state of our understanding of sleep and circadian abnormalities in HD. I also outline a set of simple rules that can be followed to improve the chances of a good night's sleep, since preventing any 'preventable' symptoms is the a logical first step in treating disease. The long-term impact of sleep disruption in HD is unknown. There have been no large-scale systematic studies of in sleep in HD. Furthermore, there has never been a study of the efficacy of pharmaceuticals that are typically used to treat sleep deficits in HD patients. Thus treatment of sleep disturbance in HD is necessarily empirical. A better understanding of the relationship between sleep/circadian abnormalities and HD pathology is needed, if treatment of this aspect of HD is to be optimized.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23099415     DOI: 10.1016/j.expneurol.2012.10.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  46 in total

1.  Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.

Authors:  Benjamin Smarr; Tamara Cutler; Dawn H Loh; Takashi Kudo; Dika Kuljis; Lance Kriegsfeld; Cristina A Ghiani; Christopher S Colwell
Journal:  J Neurosci Res       Date:  2019-07-29       Impact factor: 4.164

2.  Nocturnal Post-arousal Chorea and Repetitive Ballistic Movement in Huntington's Disease.

Authors:  Surabhi Ranjan; Scott Kohler; Madaline B Harrison; Mark Quigg
Journal:  Mov Disord Clin Pract       Date:  2015-11-27

3.  Nigrostriatal Dopamine Acting on Globus Pallidus Regulates Sleep.

Authors:  Mei-Hong Qiu; Qiao-Ling Yao; Ramalingam Vetrivelan; Michael C Chen; Jun Lu
Journal:  Cereb Cortex       Date:  2014-10-14       Impact factor: 5.357

4.  Degeneration of ipRGCs in Mouse Models of Huntington's Disease Disrupts Non-Image-Forming Behaviors Before Motor Impairment.

Authors:  Meng-Syuan Lin; Po-Yu Liao; Hui-Mei Chen; Ching-Pang Chang; Shih-Kuo Chen; Yijuang Chern
Journal:  J Neurosci       Date:  2018-12-26       Impact factor: 6.167

Review 5.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

6.  Sex-dependent behavioral impairments in the HdhQ350/+ mouse line.

Authors:  Jessica K Cao; Peter J Detloff; Richard G Gardner; Nephi Stella
Journal:  Behav Brain Res       Date:  2017-09-18       Impact factor: 3.332

Review 7.  Alteration of GABAergic neurotransmission in Huntington's disease.

Authors:  Maurice Garret; Zhuowei Du; Marine Chazalon; Yoon H Cho; Jérôme Baufreton
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

8.  A systems approach identifies networks and genes linking sleep and stress: implications for neuropsychiatric disorders.

Authors:  Peng Jiang; Joseph R Scarpa; Karrie Fitzpatrick; Bojan Losic; Vance D Gao; Ke Hao; Keith C Summa; He S Yang; Bin Zhang; Ravi Allada; Martha H Vitaterna; Fred W Turek; Andrew Kasarskis
Journal:  Cell Rep       Date:  2015-04-23       Impact factor: 9.423

9.  Early-onset sleep defects in Drosophila models of Huntington's disease reflect alterations of PKA/CREB signaling.

Authors:  Erin D Gonzales; Anne K Tanenhaus; Jiabin Zhang; Ryan P Chaffee; Jerry C P Yin
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

10.  Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.

Authors:  Simon P Fisher; Michael D Schwartz; Sarah Wurts-Black; Alexia M Thomas; Tsui-Ming Chen; Michael A Miller; Jeremiah B Palmerston; Thomas S Kilduff; Stephen R Morairty
Journal:  Sleep       Date:  2016-02-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.